Sponsor or institution
Clinical trials and research at Immunova Therapeutics, LLC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $3.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Engineered CD4+ T cells targeting KK‑LC‑1 for triple‑negative breast cancer
This project creates engineered CD4+ T cells that recognize the KK‑LC‑1 tumor antigen to help people with HLA‑DR13-positive triple‑negative breast cancer.
-
Creating engineered T cells to fight aggressive breast cancer
This study is testing a new treatment for triple-negative breast cancer that uses specially modified immune cells to help your body fight the cancer better, and it's aimed at patients who haven't had success with other treatments.
-
Creating a new vaccine to treat prostate cancer
This study is testing a new type of vaccine that could help fight prostate cancer in patients with specific tumors, aiming to boost the body's immune response without needing special cells, and it hopes to improve treatment results based on encouraging early findings in mice.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.